부산대학교 도서관

Garcia MA; Kalecinski J; Oriol M; Bonne A; Lofti M; Espenel S; Tinquaut F; Fournel P; Collard O; Vassal C; Rivoirard R; Regnier V; Chauvin F; Bourmaud A

Patient Preference and Adherence, Vol Volume 12, Pp 1853-1861 (2018)

Pautier P; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Italiano A; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Piperno-Neumann S; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Chevreau C; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Penel N; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Firmin N; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Boudou-Rouquette P; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Bertucci F; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Lebrun-Ly V; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Ray-Coquard I; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Kalbacher E; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Bompas E; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Collard O; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Isambert N; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Guillemet C; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Rios M; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Le Cesne A; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Balleyguier C; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Archambaud B; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.; Duffaud F; From the Departments of Medical Oncology (P.P., A.L.C.), Radiology (C.B.), and Biostatistics and Epidemiology (B.A.), Institut Gustave-Roussy, and Oncostat, INSERM Unité 1018, Labeled Ligue Contre le Cancer (B.A.), Villejuif, the Department of Medical Oncology, Institut Bergonié, and the Faculty of Medicine, University of Bordeaux, Bordeaux (A.I.), the Department of Medical Oncology, Institut Curie (S.P.-N.), and the Department of Medical Oncology, Hôpital Cochin-Port Royal (P.B.-R.), Paris, the Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (C.C.), Lille University, and the Department of Medical Oncology, Centre Oscar Lambret, Lille (N.P.), the Department of Medical Oncology, Institut Régional du Cancer, INSERM Unité 1194, Institut de Recherche en Cancérologie de Montpellier, and the University of Montpellier, Montpellier (N.F.), the Department of Medical Oncology, Institut Paoli-Calmettes (F.B.), the Department of Medical Oncology, La Timone University Hospital (F.D.), and Aix-Marseille Université (F.B., F.D.), Marseille, the Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges (V.L.-L.), the Department of Medical Oncology, Centre Léon Bérard, and University Claude-Bernard Lyon 1, Lyon (I.R.-C.), the Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon-Hôpital Jean-Minjoz, Besançon (E.K.), Institut de Cancérologie de l'Ouest, Angers-Nantes (E.B.), Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez (O.C.), Centre Georges-François Leclerc, Dijon (N.I.), the Department of Medical Oncology, Centre Paul Papin, Rouen (C.G.), and Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy (M.R.) - all in France.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Blay JY; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.; Schiffler C; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Bouché O; CHU & Université de Reims, Reims, France.; Brahmi M; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Duffaud F; Hôpital La Timone & Université Aix-Marseille, Marseille, France.; Toulmonde M; Institut Bergonié, Bordeaux, France.; Landi B; Hôpital Européen George Pompidou, Paris, France.; Lahlou W; Hôpital Européen George Pompidou, Paris, France.; Pannier D; Centre Oscar Lambret & Université Lille, Lille, France.; Bompas E; Institut Cancérologie de l'Ouest, Nantes, France.; Bertucci F; Institut Paoli-Calmette & Université Aix-Marseille, Marseille, France.; Chaigneau L; CHU Besançon, Besançon, France.; Collard O; Hôpital Privé de la Loire, Saint-Etienne, France.; Pracht M; Centre Eugene Marquis, Rennes, France.; Henon C; Institut Gustave Roussy, Villejuif, France.; Ray-Coquard I; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Armoun K; CHU & Université de Reims, Reims, France.; Salas S; Hôpital La Timone & Université Aix-Marseille, Marseille, France.; Spalato-Ceruso M; Institut Bergonié, Bordeaux, France.; Adenis A; Centre Oscar Lambret & Université Lille, Lille, France; Institut de Cancerologie de Montpellier & CLCC Val d'Aurelle, Montpellier, France.; Verret B; Institut de Cancerologie de Montpellier & CLCC Val d'Aurelle, Montpellier, France.; Penel N; Centre Oscar Lambret & Université Lille, Lille, France.; Moreau-Bachelard C; Institut Cancérologie de l'Ouest, Nantes, France.; Italiano A; Institut Bergonié, Bordeaux, France.; Dufresne A; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Metzger S; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Chabaud S; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Perol D; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.; Le Cesne A; Institut Gustave Roussy, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Blay JY; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.; Devin Q; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Duffaud F; Hopital La Timone, Marseille, France.; Toulmonde M; Institut Bergonié, Bordeaux, France.; Firmin N; Institut de Cancérologi Val d'Aurelle, Montpellier, France.; Collard O; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France; Hopitaux Privés de la Loire, St Etienne, France.; Bompas E; Institut de Cancérologie de l'Ouest, Nantes, France.; Verret B; Hopitaux Privés de la Loire, St Etienne, France; Institut Gustave Roussy, Villejuif, France.; Ray-Coquard I; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Salas S; Hopital La Timone, Marseille, France.; Henon C; Hopitaux Privés de la Loire, St Etienne, France; Institut Gustave Roussy, Villejuif, France.; Honoré C; Hopitaux Privés de la Loire, St Etienne, France.; Brahmi M; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Dufresne A; Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Pracht M; Centre Eugene Marquis, Rennes, France.; Hervieu A; Centre George-François Leclerc, Dijon, France.; Penel N; Centre Oscar Lambret, Lille, France.; Bertucci F; Institut Paoli-Calmettes, Marseille, France.; Rios M; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France.; Saada-Bouzid E; Centre Antoine Lacassagne, Nice, France.; Soibinet P; Institut Jean Godinot, Reims, France.; Perol D; Centre Léon Bérard, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France; Direction Recherche Clinique et Innovation, Lyon, France.; Chabaud S; Centre Léon Bérard, Lyon, France; Centre de Recherche en Cancérologie de Lyon, Lyon, France; Direction Recherche Clinique et Innovation, Lyon, France.; Italiano A; Institut Bergonié, Bordeaux, France.; Cesne AL; Institut Gustave Roussy, Villejuif, France.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Ray-Coquard IL; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; Savoye AM; GINECO and Institut Jean Godinot, Reims, France.; Schiffler C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France.; Mouret-Reynier MA; GINECO and Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.; Derbel O; GINECO and Institut de Cancérologie, Hôpital Privé Jean Mermoz, Lyon, France.; Kalbacher E; GINECO and Centre Hospitalier Universitaire Jean Minjoz, Besançon, France.; LeHeurteur M; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France.; Martinez A; GINECO and Institut Claudius Régaud, Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France.; Cornila C; GINECO and Centre Hospitalier Régional d'Orléans, Orleans, France.; Martinez M; GINECO and Clinique Pasteur, Toulouse, France.; Bengrine Lefevre L; GINECO and Centre Georges-François Leclerc, Dijon, France.; Priou F; GINECO and Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France.; Cloarec N; GINECO and Centre Hospitalier Henri Duffaut d'Avignon, Avignon, France.; Venat L; GINECO and Centre Hospitalier Universitaire Dupuytren, Limoges, France.; Selle F; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.; Berton D; GINECO and Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France.; Collard O; GINECO and Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, France.; Center of Medical Oncology, Hôpital Privé de la Loire, Saint-Etienne, France.; Coquan E; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France.; Le Saux O; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France.; Cancer Research Center of Lyon (CRCL), UMR INSERM 1052, Centre Léon Bérard, CNRS 5286, Lyon, France.; Treilleux I; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France.; Gouerant S; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France.; Angelergues A; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.; Joly F; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France.; Tredan O; GINECO and Department of Medical Oncology, Centre Léon Bérard, Lyon, France.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Bourien H; Eugene Marquis Cancer Center, Rennes, France.; Lefevre LB; Centre Georges Francois Leclerc, Dijon, France.; Mouret-Reynier MA; Centre Jean Perrin, Clermont Ferrand, France.; Asselain B; ARCAGY-GINECO, Paris, France.; Lucas B; Oncologie, Clinique Pasteur-CFRO, Brest, France.; Gavoille C; Institut de Cancérologie de Lorraine, Vandoeuvre Les Nancy, France.; Cornila C; Centre Hospitalier Régional d'Orléans, Orléans, France.; Gavoille L; Centre d'Oncologie de Gentilly, Nancy, France.; Colomba E; Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France.; Patsouris A; ICO Pays de loire, Angers, France.; Fabbro M; ICM Regional Cancer Institute of Montpellier, Montpellier, France.; Chakiba C; Institut Bergonié, Bordeaux, France.; Toussaint P; Centre Léon Bérard, Lyon, France.; Simon H; Hôpital Morvan - Centre Hospitalier Universitaire, Brest, France.; Berton D; Institut de Cancérologie de l'Ouest (ICO) René Gauducheau, Saint-Herblain, France.; Garbay D; Clinique Tivoli Ducos, Bordeaux, France.; Tixidre CG; Hôpital Privé de Provence, Aix en Provence, France.; Coeffic D; Hôpital Privé de Provence, Aix en Provence, France.; Morvan A; ARCAGY-GINECO, Paris, France.; Collard O; Hôpital Privé de la Loire (HPL), Saint-Etienne, France.; DE LA Motte Rouge T; Eugene Marquis Cancer Center, Rennes, France; t.delamotterouge@rennes.unicancer.fr.

Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Debaudringhien M; Lille University, Medical School, Lille, France.; Blay JY; Medical Oncology Department, Centre Léon Bérard, Lyon, France.; Bimbai AM; Clinical Research Department, Centre Oscar Lambret, Lille, France.; Bonvalot S; Department of Surgical Oncology, Institut Curie, Paris, France.; Italiano A; Medical Oncology Department, Institut Bergonié, Bordeaux, France.; Rousset-Jablonski C; Departments of Medical Oncology, Lyon, France.; Corradini N; Pediatric Oncology, Centre Léon Bérard, Lyon, France.; Piperno-Neumann S; Medical Oncology Department, Institut Curie, Paris, France.; Chevreau C; Medical Oncology Department, Institut Claudius Regaud, Oncopole, Toulouse, France.; Kurtz JE; Medical Oncology Department, Strasbourg University Hospital, Strasbourg, France.; Guillemet C; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.; Bompas E; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Collard O; Medical Oncology Department, Institut de Cancérologie de Loire, Saint-Priest-en-Jarez, France.; Salas S; Medical Oncology Department, Hôpital La Timone University Hospital, Marseille, France.; Le Cesne A; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Orbach D; SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), PSL Research University, Institut Curie, Paris, France.; Thery J; Clinical Research Department, Centre Oscar Lambret, Lille, France.; Le Deley MC; Clinical Research Department, Centre Oscar Lambret, Lille, France; CESP, INSERM, Paris-Saclay University, Paris-Sud University, UVSQ, Villejuif, France.; Mir O; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Penel N; Lille University, Medical School, Lille, France; Medical Oncology, Centre Oscar Lambret, Lille, France. Electronic address: n-penel@o-lambret.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Pautier P; Department of Medical Oncology, University Paris-Saclay, Gustave-Roussy, Villejuif, France. Electronic address: patricia.pautier@gustaveroussy.fr.; Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris Sciences et Lettres Research University, Paris, France.; Chevreau C; Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Penel N; Lille University and Department of Medical Oncology, Centre Oscar-Lambret, Lille, France.; Firmin N; Department of Medical Oncology, Institut du Cancer de Montpellier and Montpellier University, Montpellier, France.; Boudou-Rouquette P; Department of Medical Oncology, Hôpital Cochin, Paris, France.; Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Balleyguier C; Department of Radiology, University Paris-Saclay, Gustave-Roussy, Villejuif, France.; Lebrun-Ly V; Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges, France.; Ray-Coquard I; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude-Bernard, Lyon, France.; Kalbacher E; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon, France.; Bardet A; Bureau of Biostatistics and Epidemiology, University Paris-Saclay, Gustave-Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; Bompas E; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers-Nantes, France.; Collard O; Department of Medical Oncology, Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, France.; Isambert N; Department of Medical Oncology, Centre Georges-François-Leclerc, Dijon, France.; Guillemet C; Department of Medical Oncology, Centre Henri-Becquerel, Rouen, France.; Rios M; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, France.; Archambaud B; Bureau of Biostatistics and Epidemiology, University Paris-Saclay, Gustave-Roussy, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; Duffaud F; Department of Medical Oncology, La Timone University Hospital, Marseille, France.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Fayet Y; EMS Team-Human and Social Sciences Department, Centre Léon Bérard, 69008 Lyon, France.; Research on Healthcare Performance RESHAPE, INSERM U1290, Université Claude Bernard Lyon 1, 69008 Lyon, France.; Chevreau C; ICR IUCT-Oncopole, 31000 Toulouse, France.; Decanter G; Department of Surgical Oncology, Oscar Lambret Center, 59000 Lille, France.; Dalban C; Department of Clinical Research and Innovation, Centre Léon Bérard, 69008 Lyon, France.; Meeus P; Department of Surgery, Centre Léon Bérard, 69008 Lyon, France.; Carrère S; Institut de Recherche en Cancérologie Montpellier, INSERM U1194, 34000 Montpellier, France.; Haddag-Miliani L; Service D'imagerie Diagnostique, Institut Gustave Roussy, 94800 Villejuif, France.; Le Loarer F; Department of Pathology, Institut Bergonié, 33000 Bordeaux, France.; Causeret S; Centre Georges François Leclerc, 21000 Dijon, France.; Orbach D; Centre Oncologie SIREDO (Soins, Innovation et Recherche en Oncologie de l'Enfant, de l'aDOlescents et de L'adulte Jeune), Institut Curie, Université de Recherche Paris Sciences et Lettres, 75005 Paris, France.; Kind M; Radiologue, Département D'imagerie Médicale, Institut Bergonié, 33000 Bordeaux, France.; Le Nail LR; Department of Orthopaedic Surgery, CHU de Tours, Faculté de Médecine, Université de Tours, 37000 Tours, France.; Ferron G; INSERM CRCT19 ONCO-SARC (Sarcoma Oncogenesis), Institut Claudius Regaud-Institut Universitaire du Cancer, 31000 Toulouse, France.; Labrosse H; CRLCC Léon Berard, Oncology Regional Network ONCO-AURA, 69008 Lyon, France.; Chaigneau L; Department of Medical Oncology, CHRU Jean Minjoz, 25000 Besançon, France.; Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.; Ruzic JC; CHU Réunion, 97410 Saint-Pierre, France.; Le Brun Ly V; Service D'oncologie Médicale, CHU Dupuytren, 87000 Limoges, France.; Farsi F; CRLCC Léon Berard, Oncology Regional Network ONCO-AURA, 69008 Lyon, France.; Bompas E; Medical Oncology Department, ICO, 44800 Saint Herblain, France.; Noal S; UCP Sarcome, Centre François Baclesse, 14000 Caen, France.; Vozy A; Department of Medical Oncology, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Sorbonne University, 75013 Paris, France.; Ducoulombier A; Centre Antoine-Lacassagne, 06000 Nice, France.; Bonnet C; Service d'Oncologie Médicale Hôpital Saint Louis, 75010 Paris, France.; Chabaud S; Department of Clinical Research and Innovation, Centre Léon Bérard, 69008 Lyon, France.; Ducimetière F; Equipe EMS, Centre Léon Bérard, 69008 Lyon, France.; Tlemsani C; Service d'Oncologie Médicale, Hôpital Cochin, Institut du Cancer Paris CARPEM, Université de Paris, APHP Centre, 75014 Paris, France.; INSERM U1016-CNRS UMR8104, Institut Cochin, Institut du Cancer Paris CARPEM, Université de Paris, APHP Centre, 75014 Paris, France.; Ropars M; Orthopaedic and Trauma Department, Pontchaillou University Hospital, University of Rennes 1, 35000 Rennes, France.; Collard O; Département d'Oncologie Médicale, Hôpital Privé de la Loire, 42100 Saint-Etienne, France.; Michelin P; Service D'imagerie Médicale, CHU Hopitaux de Rouen-Hopital Charles Nicolle, 76000 Rouen, France.; Gantzer J; Department of Medical Oncology, Strasbourg-Europe Cancer Institute (ICANS), 67033 Strasbourg, France.; Dubray-Longeras P; Oncology Department, Centre Jean Perrin, 63011 Clermont-Ferrand, France.; Rios M; Department of Medical Oncology, Cancer Institute of Lorraine-Alexis Vautrin, 54500 Vandoeuvre Les Nancy, France.; Soibinet P; Department of Hepato-Gastroenterology and Digestive Oncology, Reims University Hospital, 51000 Reims, France.; Le Cesne A; Medical Oncology, Insitut Gustave Roussy, 94800 Villejuif, France.; Duffaud F; Department of Medical Oncology, CHU La Timone and Aix-Marseille Université (AMU), 13005 Marseille, France.; Karanian M; Department of Pathology, Lyon University Hospital, 69008 Lyon, France.; Gouin F; Department of Surgery, Centre Léon Bérard, 69008 Lyon, France.; Tétreau R; Medical Imaging Center, Institut du Cancer, 34000 Montpellier, France.; Honoré C; Department of Surgical Oncology, Gustave Roussy, Villejuif 94800, France.; Coindre JM; Department of Pathology, Institut Bergonié, 33000 Bordeaux, France.; Ray-Coquard I; Department of Medical Oncology, Centre Leon Berard, 69008 Lyon, France.; Bonvalot S; Department of Surgical Oncology, Institut Curie, Université Paris Sciences et Lettres, 75005 Paris, France.; Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon University, 69008 Lyon, France.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Voute M; CHU Clermont-Ferrand, Plateforme d'Investigation Clinique/CIC Inserm 1405, Clermont-Ferrand, France.; Riant T; Unité douleur, Le Confluent, Catherine de Sienne Center, Nantes, France.; Amodéo JM; CH Princesse Grace, Principauté de Monaco, France.; André G; CH Emile Roux, Le Puy-en-Velay, France.; Barmaki M; Département douleur, Clinique mutualiste, Lyon, France.; Collard O; Centre d'Evaluation et de Traitement de la Douleur, Clinique Sainte Clotilde, Ile de la Réunion, France.; Colomb C; Consultation douleur, CH Ploermel, Ploermel, France.; Créac'h C; Centre d'Evaluation et de Traitement de la Douleur, CHU Sainte Etienne, Saint Etienne, France.; Deleens R; Centre d'Evaluation et de Traitement de la Douleur, CHU, Rouen, France.; Delorme C; Centre d'Evaluation et de Traitement de la Douleur, Bayeux, Bayeux, CH, France.; de Montgazon G; Unité douleur, CH La Rochelle, La Rochelle, France.; Dixneuf V; Evaluation et de Traitement de la Douleur, Clinique Brétéché, Nantes, France.; Dy L; Evaluation et de Traitement de la Douleur, Clinique mutualiste de la porte de l'orient, Lorient, France.; Gaillard J; Centre de la Douleur, Clinique CMCM, Le Mans, France.; Gov C; Centre d'Evaluation et de Traitement de la Douleur, Hôpital neurologique, Bron, France.; Kieffer X; Centre de la Douleur Chronique et Rebelle, CH Versailles, Le Chesnay, France.; Lanteri-Minet M; Département d'Evaluation et Traitement de la Douleur, Hopital de Cimiez, Nice, France.; Le Borgne JM; Unité d'Evaluation et Traitement de la Douleur, CH Laon, Laon, France.; Le Caër F; CH Jacques Monod, Flers, France.; Maamar F; CHI Fréjus Saint Raphaëlle, Fréjus, France.; Maindet C; Centre de la Douleur, Hôpital Albert Michallon, La Tronche, France.; Marcaillou F; Centre d'Evaluation et de Traitement de la Douleur, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Plantevin F; Centre d'Evaluation et de Traitement de la Douleur, CH Mâcon, Mâcon, France.; Pluchon YM; Centre d'Evaluation et de Traitement de la Douleur, CHD Vendée, La Roche sur Yon, France.; Rioult B; Unité douleur, Le Confluent, Catherine de Sienne Center, Nantes, France.; Rostaing S; Institut Sainte Catherine, Avignon, France.; Salvat E; Centre d'Evaluation et de Traitement de la Douleur, Hôpital de Hautepierre, Strasbourg, France.; Sep Hieng V; CH Lisieux, Lisieux, France.; Sorel M; Centre de la Douleur, CH Nemours, Nemours, France.; Vergne-Salle P; Centre de la Douleur, CHU Dupuytren, Limoges, France.; Morel V; CHU Clermont-Ferrand, Plateforme d'Investigation Clinique/CIC Inserm 1405, Clermont-Ferrand, France.; de Chazeron I; Service de Psychiatrie B, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Pickering G; CHU Clermont-Ferrand, Plateforme d'Investigation Clinique/CIC Inserm 1405, Clermont-Ferrand, France.; Inserm, CIC 1405, UMR Neurodol 1407, Clermont-Ferrand, France.; Laboratoire de Pharmacologie, Faculté de médecine Clermont-Ferrand, Clermont Université, Clermont-Ferrand, France.

Publisher: Wiley Country of Publication: England NLM ID: 9801774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2149 (Electronic) Linking ISSN: 10903801 NLM ISO Abbreviation: Eur J Pain Subsets: MEDLINE